SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CKK'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.92A	1iepA-3c1xA: 30.3	1iepA-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.92A	1iepB-3c1xA: 26.1	1iepB-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.94A	1iepB-3c1xA: 26.1	1iepB-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.96A	2hyyA-3c1xA: 26.5	2hyyA-3c1xA: 32.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.93A	2hyyB-3c1xA: 26.4	2hyyB-3c1xA: 32.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 TYR A1159 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.98A	2oiqA-3c1xA: 26.6	2oiqA-3c1xA: 32.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 TYR A1159 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.94A	2pl0A-3c1xA: 25.5	2pl0A-3c1xA: 28.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	GLY A1085 VAL A1092 ALA A1108 LEU A1140 LEU A1157 TYR A1159 MET A1160 GLY A1163 MET A1211 ALA A1221	None CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-4.8A) CKK A1500 (-4.7A) CKK A1500 (-4.5A) None CKK A1500 ( 4.5A) CKK A1500 (-3.6A) CKK A1500 (-3.4A)	0.50A	2wgjA-3c1xA: 28.5	2wgjA-3c1xA: 80.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 GLY A1163 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 ( 4.5A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.49A	3cs9B-3c1xA: 30.9	3cs9B-3c1xA: 33.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	GLU A1127 GLY A1163 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.66A	3cs9B-3c1xA: 30.9	3cs9B-3c1xA: 33.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A1108 GLU A1127 MET A1131 PHE A1200 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.8A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.83A	3cs9C-3c1xA: 26.7	3cs9C-3c1xA: 33.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	VAL A1092 ALA A1108 GLU A1127 HIS A1202 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-4.2A) CKK A1500 (-4.5A)	0.79A	3gcsA-3c1xA: 20.2	3gcsA-3c1xA: 22.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.97A	3k5vB-3c1xA: 29.7	3k5vB-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	1.02A	3ms9A-3c1xA: 29.9	3ms9A-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.99A	3ms9B-3c1xA: 26.2	3ms9B-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	1.01A	3mssA-3c1xA: 26.5	3mssA-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_C_STIC1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.98A	3mssC-3c1xA: 30.0	3mssC-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 GLU A1127 MET A1131 GLY A1163 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.91A	3mssD-3c1xA: 26.5	3mssD-3c1xA: 32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A1092 ALA A1108 GLU A1127 MET A1131 TYR A1159 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.84A	3oezB-3c1xA: 26.8	3oezB-3c1xA: 32.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A1108 GLU A1127 MET A1131 GLY A1163 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 ( 4.5A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.81A	3oxzA-3c1xA: 30.3	3oxzA-3c1xA: 34.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_2 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	LEU A1157 MET A1160 ASP A1164	CKK A1500 (-4.7A) None CKK A1500 (-3.7A)	0.61A	3v5wA-3c1xA: 20.1	3v5wA-3c1xA: 18.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 LEU A1140 LEU A1157 MET A1160 GLY A1163 ASP A1164	CKK A1500 (-3.2A) CKK A1500 (-4.8A) CKK A1500 (-4.7A) None CKK A1500 ( 4.5A) CKK A1500 (-3.7A)	0.53A	3zbfA-3c1xA: 30.6	3zbfA-3c1xA: 35.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A1092 ALA A1108 LEU A1157 MET A1160 GLY A1163 ALA A1221	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-4.7A) None CKK A1500 ( 4.5A) CKK A1500 (-3.4A)	0.75A	4anqA-3c1xA: 25.8	4anqA-3c1xA: 33.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A1092 ALA A1108 GLU A1127 ILE A1130 MET A1131 TYR A1159 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) None CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	1.00A	4bkjA-3c1xA: 24.9	4bkjA-3c1xA: 32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 GLU A1127 ILE A1130 MET A1131 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) None CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.96A	4bkjB-3c1xA: 25.0	4bkjB-3c1xA: 32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 GLU A1127 ILE A1130 MET A1131 ALA A1221	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) None CKK A1500 (-3.4A) CKK A1500 (-3.4A)	1.05A	4bkjB-3c1xA: 25.0	4bkjB-3c1xA: 32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 11	GLY A1085 GLY A1087 VAL A1092 ALA A1108 TYR A1159 GLY A1163	None None CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-4.5A) CKK A1500 ( 4.5A)	0.90A	4ckiA-3c1xA: 26.5	4ckiA-3c1xA: 31.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A1092 ALA A1108 GLU A1127 ILE A1130 MET A1131 TYR A1159 ALA A1221 ASP A1222	CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-3.4A) None CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.99A	4csvA-3c1xA: 27.1	4csvA-3c1xA: 33.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 8	GLY A1087 VAL A1092 ALA A1108 MET A1160 ASP A1164	None CKK A1500 ( 4.3A) CKK A1500 (-3.2A) None CKK A1500 (-3.7A)	0.92A	4l9iB-3c1xA: 17.0	4l9iB-3c1xA: 24.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	GLU A1127 MET A1131 LEU A1195 ALA A1221 ASP A1222	CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.4A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	1.16A	4qrcA-3c1xA: 24.4	4qrcA-3c1xA: 32.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 GLU A1127 MET A1131 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.89A	4tyjA-3c1xA: 26.7	4tyjA-3c1xA: 31.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 LEU A1195 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-4.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.53A	4uxqA-3c1xA: 25.6	4uxqA-3c1xA: 30.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A1108 GLU A1127 MET A1131 LEU A1195 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.86A	4v01A-3c1xA: 27.5	4v01A-3c1xA: 32.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A1108 GLU A1127 MET A1131 LEU A1195 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-3.4A) CKK A1500 (-4.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.81A	4v01B-3c1xA: 27.2	4v01B-3c1xA: 32.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 GLU A1127 LEU A1195 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-4.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.85A	4v04A-3c1xA: 25.9	4v04A-3c1xA: 32.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 GLU A1127 LEU A1195 HIS A1202 ALA A1221 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-4.4A) CKK A1500 (-4.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A)	0.89A	4v04B-3c1xA: 26.4	4v04B-3c1xA: 32.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	ILE A1084 GLY A1085 VAL A1092 ALA A1108 MET A1160	CKK A1500 ( 4.4A) None CKK A1500 ( 4.3A) CKK A1500 (-3.2A) None	0.52A	5lw1B-3c1xA: 19.3	5lw1B-3c1xA: 14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ILE A1084 GLY A1085 VAL A1092 ALA A1108 LEU A1157 TYR A1159 GLY A1163	CKK A1500 ( 4.4A) None CKK A1500 ( 4.3A) CKK A1500 (-3.2A) CKK A1500 (-4.7A) CKK A1500 (-4.5A) CKK A1500 ( 4.5A)	0.66A	5mafA-3c1xA: 22.4	5mafA-3c1xA: 11.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 PHE A1200 HIS A1202 ASP A1222	CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 ( 4.8A) CKK A1500 (-4.2A) CKK A1500 (-4.5A)	0.65A	5mo4A-3c1xA: 26.4	5mo4A-3c1xA: 30.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ILE A1084 GLY A1085 ALA A1108 GLU A1127 TYR A1159 GLY A1163	CKK A1500 ( 4.4A) None CKK A1500 (-3.2A) CKK A1500 (-3.4A) CKK A1500 (-4.5A) CKK A1500 ( 4.5A)	0.96A	5vc3A-3c1xA: 21.7	5vc3A-3c1xA: 25.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	3c1x	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	MET A1160 GLY A1163 ARG A1203 ALA A1221	None CKK A1500 ( 4.5A) None CKK A1500 (-3.4A)	0.57A	6hd6B-3c1xA: 29.6	6hd6B-3c1xA: 13.54

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1IEP_A_STIA201_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.92A","1iepA-3c1xA:30.3",null],["1IEP_B_STIB202_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.92A","1iepB-3c1xA:26.1","1iepA-3c1xA:32.63"],["1IEP_B_STIB202_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;MET A1131;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.94A","1iepB-3c1xA:26.1","1iepB-3c1xA:32.63"],["2HYY_A_STIA600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.96A","2hyyA-3c1xA:26.5","1iepB-3c1xA:32.63"],["2HYY_B_STIB600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.93A","2hyyB-3c1xA:26.4","2hyyA-3c1xA:32.97"],["2OIQ_A_STIA1001_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A1092;ALA A1108;GLU A1127;MET A1131;TYR A1159;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.98A","2oiqA-3c1xA:26.6","2hyyB-3c1xA:32.97"],["2PL0_A_STIA200_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;TYR A1159;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.94A","2pl0A-3c1xA:25.5","2oiqA-3c1xA:32.27"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",10,"GLY A1085;VAL A1092;ALA A1108;LEU A1140;LEU A1157;TYR A1159;MET A1160;GLY A1163;MET A1211;ALA A1221","None;CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-4.8A);CKK A1500 (-4.7A);CKK A1500 (-4.5A);None;CKK A1500 ( 4.5A);CKK A1500 (-3.6A);CKK A1500 (-3.4A)","0.50A","2wgjA-3c1xA:28.5","2pl0A-3c1xA:28.99"],["3CS9_B_NILB600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;GLY A1163;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 ( 4.5A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.49A","3cs9B-3c1xA:30.9","2wgjA-3c1xA:80.71"],["3CS9_B_NILB600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLU A1127;GLY A1163;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.66A","3cs9B-3c1xA:30.9","3cs9B-3c1xA:33.79"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A1108;GLU A1127;MET A1131;PHE A1200;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.8A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.83A","3cs9C-3c1xA:26.7","3cs9B-3c1xA:33.79"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A1092;ALA A1108;GLU A1127;HIS A1202;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-4.2A);CKK A1500 (-4.5A)","0.79A","3gcsA-3c1xA:20.2","3cs9C-3c1xA:33.79"],["3K5V_B_STIB2_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.97A","3k5vB-3c1xA:29.7","3gcsA-3c1xA:22.83"],["3MS9_A_STIA1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;MET A1131;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","1.02A","3ms9A-3c1xA:29.9","3k5vB-3c1xA:32.63"],["3MS9_B_STIB1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.99A","3ms9B-3c1xA:26.2","3ms9A-3c1xA:32.63"],["3MSS_A_STIA1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;MET A1131;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","1.01A","3mssA-3c1xA:26.5","3ms9B-3c1xA:32.63"],["3MSS_C_STIC1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;MET A1131;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.98A","3mssC-3c1xA:30.0","3mssA-3c1xA:32.63"],["3MSS_D_STID1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;GLU A1127;MET A1131;GLY A1163;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.91A","3mssD-3c1xA:26.5","3mssC-3c1xA:32.63"],["3OEZ_B_STIB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;GLU A1127;MET A1131;TYR A1159;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.84A","3oezB-3c1xA:26.8","3mssD-3c1xA:32.63"],["3OXZ_A_0LIA1_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A1108;GLU A1127;MET A1131;GLY A1163;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 ( 4.5A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.81A","3oxzA-3c1xA:30.3","3oezB-3c1xA:32.27"],["3V5W_A_8PRA701_2","G-PROTEIN COUPLED RECEPTOR KINASE 2","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",3,"LEU A1157;MET A1160;ASP A1164","CKK A1500 (-4.7A);None;CKK A1500 (-3.7A)","0.61A","3v5wA-3c1xA:20.1","3oxzA-3c1xA:34.48"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;LEU A1140;LEU A1157;MET A1160;GLY A1163;ASP A1164","CKK A1500 (-3.2A);CKK A1500 (-4.8A);CKK A1500 (-4.7A);None;CKK A1500 ( 4.5A);CKK A1500 (-3.7A)","0.53A","3zbfA-3c1xA:30.6","3v5wA-3c1xA:18.96"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;LEU A1157;MET A1160;GLY A1163;ALA A1221","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-4.7A);None;CKK A1500 ( 4.5A);CKK A1500 (-3.4A)","0.75A","4anqA-3c1xA:25.8","3zbfA-3c1xA:35.92"],["4BKJ_A_STIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A1092;ALA A1108;GLU A1127;ILE A1130;MET A1131;TYR A1159;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);None;CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","1.00A","4bkjA-3c1xA:24.9","4anqA-3c1xA:33.00"],["4BKJ_B_STIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;GLU A1127;ILE A1130;MET A1131;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);None;CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.96A","4bkjB-3c1xA:25.0","4bkjA-3c1xA:32.75"],["4BKJ_B_STIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;GLU A1127;ILE A1130;MET A1131;ALA A1221","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);None;CKK A1500 (-3.4A);CKK A1500 (-3.4A)","1.05A","4bkjB-3c1xA:25.0","4bkjB-3c1xA:32.75"],["4CKI_A_ADNA2022_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"GLY A1085;GLY A1087;VAL A1092;ALA A1108;TYR A1159;GLY A1163","None;None;CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-4.5A);CKK A1500 ( 4.5A)","0.90A","4ckiA-3c1xA:26.5","4bkjB-3c1xA:32.75"],["4CSV_A_STIA1265_1","SRC-ABL TYROSINE KINASE ANCESTOR","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A1092;ALA A1108;GLU A1127;ILE A1130;MET A1131;TYR A1159;ALA A1221;ASP A1222","CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-3.4A);None;CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.99A","4csvA-3c1xA:27.1","4ckiA-3c1xA:31.51"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLY A1087;VAL A1092;ALA A1108;MET A1160;ASP A1164","None;CKK A1500 ( 4.3A);CKK A1500 (-3.2A);None;CKK A1500 (-3.7A)","0.92A","4l9iB-3c1xA:17.0","4csvA-3c1xA:33.06"],["4QRC_A_0LIA802_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLU A1127;MET A1131;LEU A1195;ALA A1221;ASP A1222","CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.4A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","1.16A","4qrcA-3c1xA:24.4","4l9iB-3c1xA:24.23"],["4TYJ_A_0LIA801_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;GLU A1127;MET A1131;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.89A","4tyjA-3c1xA:26.7","4qrcA-3c1xA:32.50"],["4UXQ_A_0LIA1752_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;LEU A1195;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-4.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.53A","4uxqA-3c1xA:25.6","4tyjA-3c1xA:31.25"],["4V01_A_0LIA1776_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A1108;GLU A1127;MET A1131;LEU A1195;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.86A","4v01A-3c1xA:27.5","4uxqA-3c1xA:30.75"],["4V01_B_0LIB1770_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A1108;GLU A1127;MET A1131;LEU A1195;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-3.4A);CKK A1500 (-4.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.81A","4v01B-3c1xA:27.2","4v01A-3c1xA:32.30"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;GLU A1127;LEU A1195;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-4.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.85A","4v04A-3c1xA:25.9","4v01B-3c1xA:32.30"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;GLU A1127;LEU A1195;HIS A1202;ALA A1221;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-4.4A);CKK A1500 (-4.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A)","0.89A","4v04B-3c1xA:26.4","4v04A-3c1xA:32.30"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ILE A1084;GLY A1085;VAL A1092;ALA A1108;MET A1160","CKK A1500 ( 4.4A);None;CKK A1500 ( 4.3A);CKK A1500 (-3.2A);None","0.52A","5lw1B-3c1xA:19.3","4v04B-3c1xA:32.30"],["5MAF_A_XINA403_1","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ILE A1084;GLY A1085;VAL A1092;ALA A1108;LEU A1157;TYR A1159;GLY A1163","CKK A1500 ( 4.4A);None;CKK A1500 ( 4.3A);CKK A1500 (-3.2A);CKK A1500 (-4.7A);CKK A1500 (-4.5A);CKK A1500 ( 4.5A)","0.66A","5mafA-3c1xA:22.4","5lw1B-3c1xA:14.63"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;PHE A1200;HIS A1202;ASP A1222","CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 ( 4.8A);CKK A1500 (-4.2A);CKK A1500 (-4.5A)","0.65A","5mo4A-3c1xA:26.4","5mafA-3c1xA:11.38"],["5VC3_A_DB8A601_1","WEE1-LIKE PROTEIN KINASE","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ILE A1084;GLY A1085;ALA A1108;GLU A1127;TYR A1159;GLY A1163","CKK A1500 ( 4.4A);None;CKK A1500 (-3.2A);CKK A1500 (-3.4A);CKK A1500 (-4.5A);CKK A1500 ( 4.5A)","0.96A","5vc3A-3c1xA:21.7","5mo4A-3c1xA:30.26"],["6HD6_B_STIB601_1","TYROSINE-PROTEIN KINASE ABL1","3c1x","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"MET A1160;GLY A1163;ARG A1203;ALA A1221","None;CKK A1500 ( 4.5A);None;CKK A1500 (-3.4A)","0.57A","6hd6B-3c1xA:29.6","5vc3A-3c1xA:25.46"]]